FMS Fresenius Medical Care AG

Fundamentals / CIK 0001333141 / EUR
Other share classes on CIK 0001333141: FMCQF

Fresenius Medical Care AG reported €19.63B in revenue and net income of €978.4M for the fiscal year ended December 31, 2025 (up 1.5% year over year), with a 25.6% gross margin and a 9.3% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open FMS in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in EUR.

€19.34B€9.67B€0FY 2016 Revenue: €16.57BFY 2016 Net Income: €1.14B2016FY 2017 Revenue: €17.78BFY 2017 Net Income: €1.28B2017FY 2018 Revenue: €16.55BFY 2018 Net Income: €1.98B2018FY 2019 Revenue: €17.48BFY 2019 Net Income: €1.20B2019FY 2020 Revenue: €17.86BFY 2020 Net Income: €1.16B2020FY 2021 Revenue: €17.62BFY 2021 Net Income: €969.3M2021FY 2022 Revenue: €19.40BFY 2022 Net Income: €673.4M2022FY 2023 Revenue: €19.45BFY 2023 Net Income: €499.0M2023FY 2024 Revenue: €19.34BFY 2024 Net Income: €537.9M2024FY 2025 Revenue: €19.63BFY 2025 Net Income: €978.4M2025

Financial statements and ratios

Reported in EUR. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in EUR · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue €19.63B €19.34B €19.45B €19.40B €17.62B €17.86B €17.48B €16.55B €17.78B €16.57B
Cost of Revenue €14.60B €14.58B €14.53B €14.50B €12.85B €12.32B €12.08B €11.39B €11.77B €10.95B
Gross Profit €5.03B €4.76B €4.93B €5.31B €5.08B €5.54B €5.40B €5.15B €6.02B €5.62B
Research & Development €158.0M €183.5M €232.0M €228.6M €220.8M €193.8M €168.0M €114.1M €111.0M €146.5M
Selling, General & Admin €3.03B €3.14B €3.20B €3.17B €2.77B €3.13B €3.03B €2.89B €3.64B €3.13B
Operating Income €1.83B €1.39B €1.37B €1.51B €1.85B €2.30B €2.27B €3.04B €2.36B €2.41B
EBITDA €3.29B €2.93B €2.98B €3.23B €3.44B €3.89B €3.82B €3.76B €3.10B €3.11B
Interest Income €69.61M €71.58M €88.22M €67.66M €73.17M €41.96M €61.62M €147.4M €51.38M -€63.40M
Interest Expense €375.2M €393.3M €420.9M €359.0M €343.8M €407.1M €486.0M €438.0M -€364.8M -€363.4M
Income Before Tax €1.51B €1.06B €1.03B €1.22B €1.57B €1.94B €1.84B €2.74B €2.00B €2.05B
Income Tax Expense €321.0M €316.1M €300.6M €325.0M €352.8M €500.6M €401.6M €511.1M €443.1M €625.4M
Net Income €978.4M €537.9M €499.0M €673.4M €969.3M €1.16B €1.20B €1.98B €1.28B €1.14B
Basic EPS €3.36 €1.83 €1.70 €2.30 €3.31 €3.96 €3.96 €6.47 €4.17 €3.74
Diluted EPS €3.36 €1.83 €1.70 €2.30 €3.31 €3.96 €3.96 €6.45 €4.16 €3.73
Basic Shares Outstanding 291.2M 293.4M 293.4M 293.2M 292.9M 294.1M 302.7M 306.5M 306.6M 305.75B
Diluted Shares Outstanding 291.2M 293.4M 293.4M 293.2M 292.9M 294.1M 302.7M 306.5M 306.6M 305.75B

Income Statement (Quarterly) · Reported in EUR · Newest filing period first.

No quarterly income statement rows are available in SEC EDGAR CompanyFacts for FMS.

Balance Sheet (Annual) · Reported in EUR · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents €1.60B €1.18B €1.40B €1.27B €1.48B €1.08B €1.01B €2.15B €978.1M €708.9M
Cash & Short-Term Investments €1.60B €1.18B €1.40B €1.27B €1.48B €1.08B €1.01B €2.15B €978.1M €708.9M
Accounts Receivable, Net -- -- -- -- -- -- €3.42B €3.23B -- --
Inventory €2.14B €2.07B €2.18B €2.30B €2.04B €1.90B €1.66B €1.47B €1.29B €1.34B
Other Current Assets €533.4M €671.8M €730.5M €919.1M €876.2M €1.05B €913.6M €804.1M €604.5M €1.14B
Total Current Assets €7.90B €7.92B €8.70B €8.20B €7.97B €7.28B €7.17B €7.85B €6.37B €6.88B
Property, Plant & Equipment, Net €3.49B €3.65B €3.78B €4.15B €4.24B €4.06B €4.19B €3.84B €3.49B €3.58B
Goodwill €13.57B €15.17B €14.65B €15.79B €14.36B €12.96B €14.02B €12.21B €12.10B €12.96B
Intangible Assets €1.25B €1.37B €1.36B €1.52B €1.46B €1.38B €1.43B €681.3M €683.1M €803.1M
Long-Term Investments €663.7M €620.8M €642.9M €773.7M €786.9M €761.1M €696.9M €649.8M €647.0M €598.2M
Other Non-Current Assets €218.2M €198.3M €223.6M €814.6M €924.6M €775.0M €752.5M €673.0M €410.0M €391.7M
Total Non-Current Assets €23.10B €25.64B €25.23B €27.55B €26.40B €24.41B €25.77B €18.40B €17.65B €18.62B
Total Assets €31.00B €33.57B €33.93B €35.75B €34.37B €31.69B €32.93B €26.24B €24.03B €25.50B
Accounts Payable -- -- -- -- -- -- €716.5M €641.3M €590.5M €575.6M
Short-Term Debt €1.60B €577.4M €944.6M €1.34B €1.92B €1.09B €2.62B €2.31B €1.64B €1.30B
Deferred Revenue (Current) €97.95M €66.73M €56.57M €63.27M €428.0M €571.4M €22.80M €37.63M €0 --
Other Current Liabilities €1.04B €1.05B €1.19B €2.98B €3.33B €3.19B €2.49B €2.38B €2.36B €2.46B
Total Current Liabilities €6.25B €5.66B €6.11B €6.47B €7.26B €6.06B €7.06B €6.27B €5.30B €5.30B
Long-Term Debt €5.69B €6.26B €6.96B €7.17B €6.65B €6.80B €6.46B €5.05B €5.79B €6.83B
Other Non-Current Liabilities €147.6M €177.6M €157.5M €988.4M €524.3M €836.0M €508.1M €622.3M €821.8M €917.4M
Total Non-Current Liabilities €10.47B €12.14B €12.99B €13.84B €13.13B €13.30B €12.65B €7.07B €7.90B €9.15B
Total Liabilities €16.72B €17.80B €19.10B €20.30B €20.39B €19.36B €19.71B €13.34B €13.20B €14.45B
Total Debt (incl. Leases) €10.80B €10.99B €12.19B €13.19B €13.32B €12.38B €18.36B €7.55B €6.68B €7.56B
Common Stock €293.4M €293.4M €293.4M €293.4M €293.0M €292.9M €304.4M €307.9M €308.1M €307.2M
Retained Earnings €12.21B €11.27B €10.92B €10.71B €10.83B €10.25B €9.45B €8.83B €7.14B €6.09B
Total Stockholders' Equity €13.31B €14.58B €13.62B €13.99B €12.70B €11.22B €11.96B €11.76B €9.82B €9.98B
Total Equity €14.28B €15.77B €14.83B €15.45B €13.98B €12.33B €13.23B €12.90B €10.83B €11.05B

Balance Sheet (Quarterly) · Reported in EUR · Newest filing period first.

Balance Sheet 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Cash & Cash Equivalents €1.60B €1.18B €1.40B €1.27B €1.48B €1.08B €1.01B €2.15B
Cash & Short-Term Investments €1.60B €1.18B €1.40B €1.27B €1.48B €1.08B €1.01B €2.15B
Accounts Receivable, Net -- -- -- -- -- -- €3.42B €3.23B
Inventory €2.14B €2.07B €2.18B €2.30B €2.04B €1.90B €1.66B €1.47B
Other Current Assets €533.4M €671.8M €730.5M €919.1M €876.2M €1.05B €913.6M €804.1M
Total Current Assets €7.90B €7.92B €8.70B €8.20B €7.97B €7.28B €7.17B €7.85B
Property, Plant & Equipment, Net €3.49B €3.65B €3.78B €4.15B €4.24B €4.06B €4.19B €3.84B
Goodwill €13.57B €15.17B €14.65B €15.79B €14.36B €12.96B €14.02B €12.21B
Intangible Assets €1.25B €1.37B €1.36B €1.52B €1.46B €1.38B €1.43B €681.3M
Long-Term Investments €663.7M €620.8M €642.9M €773.7M €786.9M €761.1M €696.9M €649.8M
Other Non-Current Assets €218.2M €198.3M €223.6M €814.6M €924.6M €775.0M €752.5M €673.0M
Total Non-Current Assets €23.10B €25.64B €25.23B €27.55B €26.40B €24.41B €25.77B €18.40B
Total Assets €31.00B €33.57B €33.93B €35.75B €34.37B €31.69B €32.93B €26.24B
Accounts Payable -- -- -- -- -- -- €716.5M €641.3M
Short-Term Debt €1.60B €577.4M €944.6M €1.34B €1.92B €1.09B €2.62B €2.31B
Deferred Revenue (Current) €97.95M €66.73M €56.57M €63.27M €428.0M €571.4M €22.80M €37.63M
Other Current Liabilities €1.04B €1.05B €1.19B €2.98B €3.33B €3.19B €2.49B €2.38B
Total Current Liabilities €6.25B €5.66B €6.11B €6.47B €7.26B €6.06B €7.06B €6.27B
Long-Term Debt €5.69B €6.26B €6.96B €7.17B €6.65B €6.80B €6.46B €5.05B
Other Non-Current Liabilities €147.6M €177.6M €157.5M €988.4M €524.3M €836.0M €508.1M €622.3M
Total Non-Current Liabilities €10.47B €12.14B €12.99B €13.84B €13.13B €13.30B €12.65B €7.07B
Total Liabilities €16.72B €17.80B €19.10B €20.30B €20.39B €19.36B €19.71B €13.34B
Total Debt (incl. Leases) €10.80B €10.99B €12.19B €13.19B €13.32B €12.38B €18.36B €7.55B
Common Stock €293.4M €293.4M €293.4M €293.4M €293.0M €292.9M €304.4M €307.9M
Retained Earnings €12.21B €11.27B €10.92B €10.71B €10.83B €10.25B €9.45B €8.83B
Total Stockholders' Equity €13.31B €14.58B €13.62B €13.99B €12.70B €11.22B €11.96B €11.76B
Total Equity €14.28B €15.77B €14.83B €15.45B €13.98B €12.33B €13.23B €12.90B

Cash Flow Statement (Annual) · Reported in EUR · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income €1.19B €740.9M €732.5M €894.3M €1.22B €1.44B €1.44B €2.23B €1.55B €1.42B
Depreciation & Amortization €1.46B €1.54B €1.61B €1.72B €1.59B €1.59B €1.55B €724.8M €735.5M €701.5M
Stock-Based Compensation -- -- -- -- -- -- €1.99M €10.74M €46.81M €27.43M
Change in Receivables -- -- -- -- -- -- -€105.8M -€164.7M -€131.7M -€246.9M
Change in Inventory -€248.7M €107.9M -€13.14M -€204.3M -€48.53M -€355.8M -€117.5M -€157.1M -€62.69M -€60.23M
Operating Cash Flow €2.68B €2.39B €2.63B €2.17B €2.49B €4.23B €2.57B €2.06B €2.19B €1.93B
Capital Expenditure -- -- -- -- -- -- -€1.12B -€1.06B -€944.5M €930.5M
Free Cash Flow -- -- -- -- -- -- €1.44B €1.00B €1.25B €2.86B
Acquisitions, Net -€15.30M -€177K -€3.14M €10.53M -€324.8M -€214.8M -€2.16B -€250.0M -€521.3M --
Purchases of Investments -€87.52M -€81.50M -€102.4M -€105.6M -€129.1M -€96.40M -€11.31M -€480.3M -- --
Sales & Maturities of Investments €83.50M €75.13M €89.59M €57.67M €144.5M €42.24M €16.62M €150.2M €256.1M --
Investing Cash Flow -€722.5M -€84.94M -€544.2M -€734.7M -€1.20B -€1.33B -€3.29B -€245.0M -€991.5M -€1.25B
Share Repurchases -€585.3M -- -- -- -- -€366.0M -€599.8M -€37.22M -€57.94M €0
Dividends Paid -- -- -- -- -- -€351.2M -€354.6M -€324.8M -€294.0M €244.3M
Financing Cash Flow -€1.40B -€2.57B -€1.86B -€1.62B -€1.02B -€2.66B -€466.6M -€681.7M -€798.6M -€519.7M
Net Change in Cash €413.8M -€241.9M €153.4M -€207.9M €400.1M €73.82M -€1.14B €1.17B €269.2M €204.2M

Cash Flow Statement (Quarterly) · Reported in EUR · Newest filing period first.

No quarterly cash flow statement rows are available in SEC EDGAR CompanyFacts for FMS.

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 25.6% 24.6% 25.3% 27.4% 28.8% 31.0% 30.9% 31.2% 33.8% 33.9%
Operating Margin 9.3% 7.2% 7.0% 7.8% 10.5% 12.9% 13.0% 18.4% 13.3% 14.5%
Net Profit Margin 5.0% 2.8% 2.6% 3.5% 5.5% 6.5% 6.9% 12.0% 7.2% 6.9%
Return on Equity (ROE) 7.4% 3.7% 3.7% 4.8% 7.6% 10.4% 10.0% 16.9% 13.0% 11.5%
Return on Assets (ROA) 3.2% 1.6% 1.5% 1.9% 2.8% 3.7% 3.6% 7.6% 5.3% 4.5%
Current Ratio 1.26x 1.40x 1.42x 1.27x 1.10x 1.20x 1.02x 1.25x 1.20x 1.30x
Quick Ratio 0.92x 1.03x 1.07x 0.91x 0.82x 0.89x 0.78x 1.02x 0.96x 1.05x
Debt to Equity 0.81x 0.75x 0.89x 0.94x 1.05x 1.10x 1.54x 0.64x 0.68x 0.76x
Revenue Growth (YoY) +1.5% -0.6% +0.3% +10.1% -1.3% +2.2% +5.6% -7.0% +7.3% +7.2%
Gross Profit Growth (YoY) +5.7% -3.4% -7.3% +4.6% -8.3% +2.6% +4.7% -14.3% +7.2% +8.5%
Operating Income Growth (YoY) +31.2% +1.7% -9.4% -18.4% -19.6% +1.5% -25.3% +28.6% -1.9% +13.2%
Net Income Growth (YoY) +81.9% +7.8% -25.9% -30.5% -16.8% -2.9% -39.5% +54.9% +11.9% +19.8%
EPS Growth (YoY) +83.6% +7.6% -26.1% -30.5% -16.4% 0.0% -38.8% +55.2% +11.5% +19.1%
Operating Cash Flow Growth (YoY) +12.4% -9.2% +21.3% -12.9% -41.2% +64.9% +24.5% -5.9% +13.4% +9.4%
Free Cash Flow Growth (YoY) -- -- -- -- -- -- +43.6% -19.5% -56.4% +215.4%
5Y Revenue / Share Growth +11.0% +14.1% +22.8% +14.0% +110878.0% +19.6% -- -- -- --
10Y Revenue / Share Growth +32.8% -- -- -- -- -- -- -- -- --
5Y Net Income / Share Growth -15.1% -53.7% -73.7% -45.0% +88334.5% +26.2% -- -- -- --
10Y Net Income / Share Growth +7.1% -- -- -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

No quarterly ratios & growth rows are available in SEC EDGAR CompanyFacts for FMS.
Source: SEC EDGAR CompanyFacts (CIK 0001333141) · from December 31, 2015 Data through December 31, 2025 · synced Nov 20, 2026, 05:08 UTC · Open in terminal